GPR176 enhances the epithelial‑mesenchymal transition in gastric cancer cells by activating the PI3K/AKT/mTOR signaling pathway
Abstract
, while GPR176 overexpression led to activation of these pathways. In summary, the present study identifies GPR176 as a novel prognostic biomarker in gastric cancer. Mechanistically, GPR176 promotes EMT and tumor progression, at least in part, through activation of the PI3K/AKT/mTOR signaling pathway.
Fields of Study & Subjects
Receptor Mechanisms and Signaling
Cancer
Lipids
and Metabolism
Estrogen and related hormone effects
Publication details
- Journal / source
- Oncology Reports
- Publisher
- Spandidos Publications
- Volume
- 55
- Issue
- 3
- Pages
- 1–17
- Publication date
- 19 January 2026
- Language
- EN